Connect with us

Hi, what are you looking for?

The CyberKnife System is a non-invasive, non-surgical, pain-free treatment option for cancer with proven results/FILE

Capital Health

Jos Hansen delivers Cyberknife robotic cancer equipment in Kenya

Jos Hansen will be installing the state-of-the-art technology at the Kenyatta University Teaching Referral and Research Hospital (KUTRRH), making it the second of its kind in Africa after Egypt.

NAIROBI, Kenya, Oct 11 — Jos Hansen East Africa, a leading healthcare solutions provider has delivered the first state-of-the-art cancer robotic equipment known as CyberKnife System into Kenya.

The equipment is expected to revolutionise cancer care.

The CyberKnife System is a non-invasive, non-surgical, pain-free treatment option for cancer with proven results. It is the only radiotherapy device that brings true robotic precision and has the ability to track, detect and correct tumour motion in real-time, for the treatment of cancer.

Equipped with a global team of engineers with the expertise to train, operate and maintain the CyberKnife System, Jos Hansen will be installing the state-of-the-art technology at the Kenyatta University Teaching Referral and Research Hospital (KUTRRH), making it the second of its kind in Africa after Egypt.

Jos Hansen (East Africa) Ltd is the exclusive distributor of Accuray Cyberknife and Tomotherapy equipment, including the next-generation Radixact System in Kenya.
Cyberknife is approved to treat a variety of cancers, including tumours in the brain, breast, liver and lung, pancreatic and prostate areas.

The robotic system has precise and accurate radiation to the cancer tumour with real-time motion synchronisation that provides intrafraction imaging that enables the tracking and correction with Automatic AI real-time.

This helps in eliminating the inconvenience and risk associated with the insertion of a needle-like probe into the tumour through the skin. The CyberKnife system neither requires surgery nor anesthesia.

It is able to reach areas of the body previously thought untreatable. It can track the position of cancer tumours.

The treatment takes only 1-5 sessions and is able to verify the cancer tumour position and offer tumour precision treatment without affecting other organs.

Speaking during the unveiling of the equipment, MD Jos hansen Group Benard W.Njoroge, explained that the company will install and maintain the Cyberknife equipment at Kenyatta University Teaching Research and Referral Hospital.

“Jos Hansen is proud to be an exclusive partner for Accuray Inc. for CyberKnife S7 System, bringing quality cancer care,” he said.

Comments

More on Capital News

Capital Health

KUTRRH becomes the first public hospital in East Africa to offer Lutetium-177 PSMA therapy, a targeted treatment for advanced prostate cancer with fewer side...

Capital Health

Ministry of Health hands over refurbished Gatundu Level 5 Hospital to Kiambu County, boosting healthcare delivery under the Universal Health Coverage agenda.

Capital Health

Health CS Aden Duale announces new measures to reduce maternal and newborn deaths, strengthen quality of care, and advance Kenya’s UHC goals.

Capital Health

The procedure involved a patient who suffered from an aortic dissection caused by a tear in the aorta's internal face.

Top stories

The Level 6 facility is all set to onboard Kenyatta University School of Medicine students per the regulatory procedures outlined by KMPDC to undertake...

Capital Health

The commencement of CyberKnife treatment services comes after an intense and much-awaited completion of the commissioning process after the launch of the CyberKnife Centre...

Top stories

NAIROBI, Kenya Sep 21 – The Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) Board has welcomed Attorney General Justin Muturi’s parliamentary confirmation that...

Capital Health

The regulatory accreditation will be valid for a renewable three-year period, allowing the School of Medicine students from Kenyatta University access the level 6...